Danske Bank’s Outset Medical OM Stock Holding History

Danske Bank’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2	Closed	-$22	–	1571
2025 Q1	$22	Buy	+2	New	+$24	﹤0.01%	1304

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Danske Bank's OM Position: Q2 2025 in Review

Danske Bank sold out of Outset Medical (OM) in Q2 2025, closing a stake of 2 shares — an estimated $22 sold.

Danske Bank first reported a position in OM in Q1 2025 and held it in 1 quarter. The position peaked at $22 in Q1 2025. 94 funds tracked by Wall St. Rank hold OM as of Q2 2025.

Danske Bank reported no remaining Outset Medical position as of Q2 2025 after selling out during the quarter.
Danske Bank sold 2 Outset Medical shares in Q2 2025, an estimated $22.
Danske Bank first reported a position in Outset Medical in Q1 2025 and held it in 1 quarter.
Danske Bank's Outset Medical position peaked at $22 in Q1 2025.
94 funds tracked by Wall St. Rank held Outset Medical as of Q2 2025.

Based on Danske Bank's 13F filing for Q2 2025, filed 18 Dec 2025.